Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LGND | Common Stock | Sale | -$505K | -5.87K | -19.74% | $86.01 | 23.9K | May 15, 2024 | Direct | F1 |
transaction | LGND | Common Stock | Sale | -$195K | -2.26K | -9.48% | $86.00 | 21.6K | May 16, 2024 | Direct | F2 |
transaction | LGND | Common Stock | Options Exercise | $11.8K | +206 | +0.95% | $57.22 | 21.8K | May 17, 2024 | Direct | |
transaction | LGND | Common Stock | Options Exercise | $98.2K | +1.54K | +7.07% | $63.62 | 23.4K | May 17, 2024 | Direct | |
transaction | LGND | Common Stock | Options Exercise | $9.97K | +145 | +0.62% | $68.74 | 23.5K | May 17, 2024 | Direct | |
transaction | LGND | Common Stock | Options Exercise | $265K | +5.02K | +21.36% | $52.84 | 28.5K | May 17, 2024 | Direct | |
transaction | LGND | Common Stock | Sale | -$435K | -5.02K | -17.6% | $86.67 | 23.5K | May 17, 2024 | Direct | F3 |
transaction | LGND | Common Stock | Sale | -$11.6K | -134 | -0.57% | $86.65 | 23.4K | May 17, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LGND | Employee Stock Option (right to buy) | Options Exercise | $0 | -206 | -2.67% | $0.00 | 7.52K | May 17, 2024 | Common Stock | 206 | $57.22 | Direct | F4 |
transaction | LGND | Employee Stock Option (right to buy) | Options Exercise | $0 | -1.54K | -7.72% | $0.00 | 18.5K | May 17, 2024 | Common Stock | 1.54K | $63.62 | Direct | F5 |
transaction | LGND | Incentive Stock Option (right to buy) | Options Exercise | $0 | -145 | -100% | $0.00* | 0 | May 17, 2024 | Common Stock | 145 | $68.74 | Direct | F6 |
transaction | LGND | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -5.02K | -23.69% | $0.00 | 16.2K | May 17, 2024 | Common Stock | 5.02K | $52.84 | Direct | F7 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.0000 to $86.1500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F2 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.0000 to $86.0350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.0300 to $86.8200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | As per the separation of OmniAb Inc. from the issuer, 4,096 stock options were vested and exercisable as of November 1, 2022, whereas 3,766 options vest in 23 substantially equal monthly installments beginning on December 1, 2022. |
F5 | Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter. |
F6 | The stock option vests as to 50% of the underlying shares on January 11, 2023 and as to the remaining on February 11, 2023. |
F7 | The stock option vests and is exercisable as to approximately 14% of the underlying shares on August 5, 2022, approximately 64% of the underlying shares in 28 substantially equal monthly installments beginning on September 5, 2022, and approximately 22% of the underlying shares in 12 substantially equal monthly installments thereafter. |